Novel bioactive compounds from Actinomycetes: a short review (1988-1992).
Novel secondary metabolites continue to be isolated from Actinomycetes. Their biological activities and chemical structures show a wide range of diversity. This short review provides information on the compounds isolated between 1988 and 1992, and highlights interesting substances discovered during screening.
Sanglier
J J
JJ
Preclinical Research, Sandoz Pharma Ltd, Basel, Switzerland.
Haag
H
H
Huck
T A
TA
Fehr
T
T
D000192:Actinomycetales / Q000378:metabolism*; D000900:Anti-Bacterial Agents / Q000096:biosynthesis / Q000302:isolation & purification*; D000970:Antineoplastic Agents / Q000302:isolation & purification*; D000998:Antiviral Agents / Q000302:isolation & purification*; D016232:Endothelins / Q000096:biosynthesis / Q000302:isolation & purification; D006540:Herbicides / Q000302:isolation & purification; D007166:Immunosuppressive Agents / Q000302:isolation & purification*; D066298:In Vitro Techniques
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D016232:Endothelins; D006540:Herbicides; D007166:Immunosuppressive Agents